Arkady Mandel is listed as an executive officer and director on 5 SEC Form D filings by 1 issuer between May 2018 and Aug 2026: THERALASE TECHNOLOGIES INC /FI (Toronto, Ontario, Canada (as filed: A6) — industry reported as "Other" — 2018–2026; $323K reported sold to 4 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Kristina Hachey (5 shared filings), Randy Bruder (5 shared filings), Guy Anderson (4 shared filings), Matthew Perraton (4 shared filings), Roger Dumoulin-White (3 shared filings) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Arkady. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Arkady Mandel and found 8 differences: Form D filed 19 days after the first sale; Form D filed 16 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.